/PRNewswire/ TrialSpark announced today the formation of Libertas Bio following the acquisition of a majority position in a portfolio of immunodermatology.
/PRNewswire/ TrialSpark today announced a new partnership with global pharmaceutical company Sanofi to explore novel methods of bringing new treatments to.